3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Brain Neoplasms
7
Glioblastoma
6
Squamous Cell Carcinoma of Head and Neck
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Gliosarcoma
5
Polycythemia Vera
4
Meningioma
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Acute
4
Head and Neck Neoplasms
4
Neoplasms
3
Leukemia
3
Laryngeal Neoplasms
3
Glioma
3
Thrombocythemia, Essential
2
Primary Myelofibrosis
2
Pharyngeal Neoplasms
2
Paranasal Sinus Neoplasms
2
Myelodysplastic Syndromes
2
Esophageal Neoplasms
2
Central Nervous System Neoplasms
2
Carcinoma, Squamous Cell
2
Tongue Neoplasms
1
Thrombosis
1
Thrombocytosis
1
Stomach Neoplasms
1
Salivary Gland Neoplasms
1
Recurrence
1
Polycythemia
1
Papillomavirus Infections
1
Interventions
Vorinostat
1
Spectroscopy, Near-Infrared
1
Phlebotomy
1
Hydroxyurea
1
Histone Deacetylase Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Polycythemia
×
Hydroxyurea
×
Clear all
NCT01645124
2012-07-20
CYTO-PV
Consorzio Mario Negri Sud
Phase 3
Terminated
365 enrolled